Morgan Stanley
NYSE:MSFinancial - Capital Markets
+$0.33 today
- Market cap
- $285.76B
- Beta
- 1.22
- P/E (TTM)
- 19.5
- EPS (TTM)
- $11.57
- Dividend yield
- 1.78%
Volume 5.15M
Average 6.07M
MS Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Morgan StanleyNYSE: MS
Investing Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Investing cash flow turns positive
Q3 FY2026 investing cash flow was $0, compared with -$10.68B a year earlier. Trailing-twelve-month investing cash flow was -$27.2B. Over 3 fiscal years it compounded at +131.5% a year.
Context
- Investing cash flow amounted to 125.4% of revenue in FY2025, up 96.9 pp from a year earlier.
- Investing cash flow grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly investing cash flow holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$6.8B.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (144.22B) USD
- Year-over-year change
- -389.6%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (144.22B) | -389.6% |
| FY2024 | 2024-12-31 | (29.46B) | -855.3% |
| FY2023 | 2023-12-31 | (3.08B) | +73.5% |
| FY2022 | 2022-12-31 | (11.63B) | +76.7% |
| FY2021 | 2021-12-31 | (49.9B) | — |
Investing Cash Flow vs competitors
How MS compares with its peers on the latest reported figures
- Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -37.5% is the 3rd highest of 6, against a peer median of -44.2%.
- Investing cash flow amounts to 21.0% of revenue for MS, versus a peer median of 19.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $177.95B USD | -1846.6% | +10.9% | 102.1% | |
| LTM Sep 2026 | $164.49B USD | -44.2% | +24.4% | 54.5% | |
| LTM Jun 2026 | $95.03B USD | +34.8% | -16.5% | 80.6% | |
| LTM Jun 2026 | $82.44B USD | -49.7% | +285.7% | 42.2% | |
| LTM Sep 2026 | $27.2B USD | -37.5% | +131.5% | 21.0% | |
| LTM Mar 2026 | $14.72B USD | +86.5% | +13.3% | 19.7% | |
| LTM Jun 2026 | $0 USD | — | +2.4% | 0.0% | |
| LTM Jun 2026 | £0 GBP | — | — | 0.0% | |
| LTM Jun 2026 | €0 EUR | — | — | 0.0% | |
| LTM Mar 2026 | ¥0 JPY | — | +85.9% | 0.0% | |
| Peer median (excluding MS) | — | -44.2% | +13.3% | 19.7% | |
Competitors are the stored peer set for MS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 15.12B | 11.18B | 9.09B | 13.53B | 16.86B |
| Depreciation & Amortization | 4.22B | 4B | 4.26B | 5.16B | 4.66B |
| Deferred Income Tax | 4M | (849M) | (463M) | 152M | 561M |
| Stock-Based Compensation | 2.09B | 1.88B | 1.71B | 1.62B | 1.93B |
| Change in Working Capital | 12.69B | (23.5B) | (49.11B) | (19.37B) | 24.07B |
| Accounts Receivables | 774M | 14.66B | 602M | (5.31B) | 0 |
| Inventory | 7.84B | 0 | 0 | 0 | 0 |
| Accounts Payables | 7.76B | (4.9B) | (3.63B) | 0 | 0 |
| Other Working Capital | (3.68B) | (33.27B) | (46.08B) | (14.06B) | 24.07B |
| Other Non-Cash Items | (143M) | 898M | 983M | 268M | 921M |
| Operating Cash Flow | 33.97B | (6.4B) | (33.54B) | 1.36B | 49B |
| Capital Expenditures | (2.31B) | (3.08B) | (3.41B) | (3.46B) | (2.9B) |
| Acquisitions (Net) | (2.65B) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (69.57B) | (29.83B) | (23.08B) | (39.19B) | (134.02B) |
| Sales of Investments | 61.57B | 45.28B | 28.39B | 37.29B | 35.17B |
| Other Investing Activities | (36.94B) | (24B) | (4.98B) | (24.1B) | (42.48B) |
| Investing Cash Flow | (49.9B) | (11.63B) | (3.08B) | (29.46B) | (144.22B) |
| Debt Repayment | 20.15B | 37.56B | 13.62B | 28.14B | 71.46B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (12.08B) | (10.87B) | (6.18B) | (4.2B) | (5.84B) |
| Dividends Paid | (4.17B) | (5.4B) | (5.76B) | (6.14B) | (6.59B) |
| Other Financing Activities | 36.37B | 430M | (4.4B) | 27.96B | 39.29B |
| Financing Cash Flow | 41.55B | 22.71B | (2.73B) | 46.76B | 98.31B |
| Effect of Forex Changes | (3.55B) | (4.28B) | 451M | (2.5B) | 3.22B |
| Net Change in Cash | 22.07B | 402M | (38.9B) | 16.15B | 6.31B |
| Free Cash Flow | 31.66B | (9.48B) | (36.95B) | (2.1B) | 46.1B |
Morgan Stanley
NYSE:MS
Intrinsic Alpha fair value
Locked
Current Price
$181.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.